Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Serum IGF-II and Cancer: Can IGF II Levels be Used to Monitor and Screen Patients Specifically for Cervical Cancer

This study is enrolling participants by invitation only.
Sponsor:
Information provided by:
Onconix, Inc
ClinicalTrials.gov Identifier:
NCT01371695
First received: June 9, 2011
Last updated: June 10, 2011
Last verified: June 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: September 2013
  Estimated Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)